During the past decade, Wojewodzki Specjalistyczny Szpital im. Dr Wl. Bieganskiego w Lodzi conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojewodzki Specjalistyczny Szpital im. Dr Wl. Bieganskiego w Lodzi" #1 sponsor was "Gilead Sciences" with 10 trials, followed by "Amgen" with 2 trials sponsored, "Bayer" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Rigshospitalet, Denmark" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewodzki Specjalistyczny Szpital im. Dr Wl. Bieganskiego w Lodzi" #1 collaborator was "Horizon 2020 - European Commission" with 1 trials as a collaborator, "IrsiCaixa" with 1 trials as a collaborator and "University College, London" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Wojewodzki Specjalistyczny Szpital im. Dr Wl. Bieganskiego w Lodzi" are "AIDS" (2 trials), "HBV" (2 trials), "Heart Failure" (2 trials), "Hepatitis C" (2 trials) and "Hepatitis C, Chronic" (2 trials). Many other conditions were trialed in "Wojewodzki Specjalistyczny Szpital im. Dr Wl. Bieganskiego w Lodzi" in a lesser frequency.

Most popular intervention types in "Wojewodzki Specjalistyczny Szpital im. Dr Wl. Bieganskiego w Lodzi" are "Drug" (14 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "TDF" (3 trials), "Copegus®" (2 trials), "Pegasys®" (2 trials) and "Placebo to match SEL 18 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wojewodzki Specjalistyczny Szpital im. Dr Wl. Bieganskiego w Lodzi" are 19 trials for "All" genders.

Currently, there are 6 active trials in "Wojewodzki Specjalistyczny Szpital im. Dr Wl. Bieganskiego w Lodzi". 1 are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Wojewodzki Specjalistyczny Szpital im. Dr Wl. Bieganskiego w Lodzi, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewodzki Specjalistyczny Szpital im. Dr Wl. Bieganskiego w Lodzi, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Wojewodzki Specjalistyczny Szpital im. Dr Wl. Bieganskiego w Lodzi has several departments that took part in Clinical trials: "Oddzial Kardiologii Wojewodzki Szpital Specjalistyczny im. W.Bieganskiego" - 2 trials, "Specjalistyczny Szpital Wojewódzki im. Biegańskiego; Klinika Chorób Zakaźnych i Hepatologii UM" - 2 trials